Some experts, fearing Delta, are having Pfizer booster shots after J&J's one-dose vaccine. "We shouldn't wait" for official recommendations, one said.
Health authorities are investigating whether reports of heart inflammation in seven US teen boys can be linked to the administration of a Pfizer shot.
These are Insider's biggest healthcare stories for May 24.
A new University of Queensland facility could develop mRNA vaccines “within months”, potentially bolstering Australia’s fight against the COVID-19 pandemic. mRNA technology is the basis of the highly successful Pfizer COVID-19 vaccine, which has been rolled out worldwide. Researchers hope the facility, instituted with a matched $2.2 million Federal Government […]
"We had such a spectacular outcome with coronavirus that we absolutely need to embark on this platform and test it," a veteran HIV researcher said.
In a recent Andreessen Horowitz podcast, Stéphane Bancel discusses how mRNA works and why it's transformative for future drug development.
Covid-19 vaccine forwarded vaccine science years, Pfizer’s CEO said, and now it’s time to use advances for other viral diseases, such as the flu. “We’ll be able to provide medical solutions for other devastating diseases,” the CEO said. The Pfizer BioNTech vaccine used a new method with messenger RNA to […]
Scientist Katalin Karikó struggled for years to convince colleagues that messenger RNA could have disease-fighting applications in humans. In 2005, she found a way to configure mRNA so that it slipped past the body’s natural defences – a discovery that paved for the way for the world’s first mRNA vaccines. […]
President Donald Trump on Tuesday announced that the US government reached a deal with Moderna for 100 million doses of its coronavirus vaccine candidate. Shares of Moderna spiked as much as 11% in premarket trading Wednesday. The company separately announced the deal is worth $US1.53 billion and gives the government […]
TD Ameritrade clients boosted their stock-market exposure for the first time in four months, a May update to the firm’s Investor Movement Index showed Monday. The index jumped to 4.35 last month from 3.9 as net buying activity ended a downturn and matched the market’s broad rally. Travel companies Southwest […]
Moderna’s 30% gain in Monday trading is making a small group of scientists and executives a fortune. The biotech company surged after announcing phase-one trials of its coronavirus vaccine successfully produced antibodies in all 45 participants. Moderna now plans to finalise phase-three studies in July before bringing its vaccine to […]
Goldman Sachs lifted its price target for Moderna stock to $US105 from $US63 on Monday after first trials for its coronavirus drug showed “encouraging” results. Moderna announced Monday that all 45 volunteers in the trial produced antibodies to protect against COVID-19 infection. Shares jumped as much as 39% on the […]
Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. Shares of the company surged 29% on Monday. The company is aiming to have the vaccine ready for emergency use in the fall. Watch Moderna trade live on Markets Insider. Read more on […]
Moderna stock surged as much as 16% early Thursday after the company announced its coronavirus vaccine candidate received FDA approval for phase 2 trials. The biotech firm is preparing for a phase 3 study to begin in the early summer with the goal of marketing the drug as early as […]
Gilead,Moderna, and Novavax have all enjoyed massive gains after announcing potential coronavirus drugs, leading their executives, scientists, and early investors to rake in millions. The profits come as global markets tank on growing coronavirus concerns. Moderna has gained the most of the three since Friday’s close, jumping 60% after announcing […]
Investors are posting multimillion-dollar gains from Moderna’s soaring stock price, profiting from the company’s bid to offer a coronavirus vaccine. Moderna spiked 30% between Monday and Tuesday’s trading sessions. The biotech firm was one of the few US stocks to post major gains while the broader market slumped on intensifying […]
Biotech company Moderna jumped as much as 22% on Tuesday after the firm shipped the first coronavirus vaccine for phase one testing in the US. Moderna submitted vials of mRNA-1273 to the National Institute of Allergy and Infectious Diseases for human testing, aiming to introduce the first preventative vaccine for […]